Cantor Fitzgerald’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Cantor Fitzgerald’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-125,000	Closed	-$34.8K	–	353
2024 Q1	$34.8K	Hold	125,000	–	–	0.01%	189
2023 Q4	$28.8K	Hold	125,000	–	–	0.01%	180
2023 Q3	$20.6K	Hold	125,000	–	–	﹤0.01%	494
2023 Q2	$19.3K	Hold	125,000	–	–	﹤0.01%	517
2023 Q1	$12.2K	Hold	125,000	–	–	﹤0.01%	621
2022 Q4	$8K	Hold	125,000	–	–	﹤0.01%	665
2022 Q3	$9K	Hold	125,000	–	–	﹤0.01%	726
2022 Q2	$14K	Buy	+125,000	New	+$27.6K	﹤0.01%	765

Other funds holding AONCW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $190M AUM 31.84% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Cantor Fitzgerald's AONCW Position: Q2 2024 in Review

Cantor Fitzgerald sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 125,000 shares — an estimated $34.8K sold.

Cantor Fitzgerald first reported a position in AONCW in Q2 2022 and held it in 8 quarters. The position peaked at $34.8K in Q1 2024. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

Cantor Fitzgerald reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
Cantor Fitzgerald sold 125,000 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $34.8K.
Cantor Fitzgerald first reported a position in American Oncology Network, Inc. Warrant in Q2 2022 and held it in 8 quarters.
Cantor Fitzgerald's American Oncology Network, Inc. Warrant position peaked at $34.8K in Q1 2024.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on Cantor Fitzgerald's 13F filing for Q2 2024, filed 14 Aug 2024.